DK1325022T3 - Fremgangsmåde til fremstilling af 21-hydroxy-6,19-oxidoprogesteron (21OH-6OP) - Google Patents

Fremgangsmåde til fremstilling af 21-hydroxy-6,19-oxidoprogesteron (21OH-6OP)

Info

Publication number
DK1325022T3
DK1325022T3 DK01984642T DK01984642T DK1325022T3 DK 1325022 T3 DK1325022 T3 DK 1325022T3 DK 01984642 T DK01984642 T DK 01984642T DK 01984642 T DK01984642 T DK 01984642T DK 1325022 T3 DK1325022 T3 DK 1325022T3
Authority
DK
Denmark
Prior art keywords
oxidoprogesterone
hydroxy
preparation
phosphorlated
acylated
Prior art date
Application number
DK01984642T
Other languages
Danish (da)
English (en)
Inventor
Adriana Silvia Veleiro
Gerardo Burton
Carlos P Lantos
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK1325022T3 publication Critical patent/DK1325022T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01984642T 2000-09-18 2001-09-17 Fremgangsmåde til fremstilling af 21-hydroxy-6,19-oxidoprogesteron (21OH-6OP) DK1325022T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00119494 2000-09-18
PCT/EP2001/010734 WO2002022646A2 (en) 2000-09-18 2001-09-17 Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)

Publications (1)

Publication Number Publication Date
DK1325022T3 true DK1325022T3 (da) 2007-02-19

Family

ID=8169774

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01984642T DK1325022T3 (da) 2000-09-18 2001-09-17 Fremgangsmåde til fremstilling af 21-hydroxy-6,19-oxidoprogesteron (21OH-6OP)

Country Status (13)

Country Link
US (4) US7071328B2 (https=)
EP (1) EP1325022B1 (https=)
JP (1) JP2004509131A (https=)
AT (1) ATE344273T1 (https=)
AU (2) AU1817902A (https=)
CA (1) CA2419960A1 (https=)
DE (1) DE60124289T2 (https=)
DK (1) DK1325022T3 (https=)
ES (1) ES2271090T3 (https=)
IL (2) IL154776A0 (https=)
PT (1) PT1325022E (https=)
SI (1) SI1325022T1 (https=)
WO (1) WO2002022646A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1325022T1 (sl) * 2000-09-18 2007-04-30 Applied Research Systems Metoda za pripravo 21-hidroksi-6,19-oksidoprogesterona (21oh-6op)
SI1330468T1 (sl) * 2000-09-18 2007-10-31 Serono Lab Ĺ˝veplovi analogi 21-hidroksi-6,19-oksido-progesterona (21oh-6op) za zdravljenje preseĺ˝ka glukokortikoidov
WO2007106385A2 (en) * 2006-03-10 2007-09-20 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment
EP1862468A1 (de) * 2006-06-02 2007-12-05 Bayer Schering Pharma Aktiengesellschaft Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
MX2015004606A (es) 2012-10-09 2017-04-04 Avery Dennison Corp Adhesivos y metodos relacionados.
US20210355154A1 (en) * 2018-09-28 2021-11-18 The Regents Of The University Of Michigan Halogenated Cholesterol Analogues and Methods of Making and Using Same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3036068A (en) * 1960-01-06 1962-05-22 Syntex Sa C-6, 19-steroidal lactones
LU77457A1 (https=) * 1977-05-31 1979-01-19
US4814333A (en) * 1987-07-28 1989-03-21 The Trustees Of Dartmouth College Method for treatment of hypercortisolemic, depressed patients
GB9606016D0 (en) * 1996-03-22 1996-05-22 Smithkline Beecham Plc Novel use
EP0903146A1 (en) * 1997-09-23 1999-03-24 Applied Research Systems ARS Holdings N.V. 21-Hydroy-6,19-oxidoprogesterone (210h-60p) as antiglucocorticoid
ATE332696T1 (de) * 1997-10-06 2006-08-15 Univ Leland Stanford Junior Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen
SI1330468T1 (sl) * 2000-09-18 2007-10-31 Serono Lab Ĺ˝veplovi analogi 21-hidroksi-6,19-oksido-progesterona (21oh-6op) za zdravljenje preseĺ˝ka glukokortikoidov
SI1325022T1 (sl) * 2000-09-18 2007-04-30 Applied Research Systems Metoda za pripravo 21-hidroksi-6,19-oksidoprogesterona (21oh-6op)

Also Published As

Publication number Publication date
ATE344273T1 (de) 2006-11-15
ES2271090T3 (es) 2007-04-16
AU2002218179B2 (en) 2006-11-16
AU1817902A (en) 2002-03-26
SI1325022T1 (sl) 2007-04-30
EP1325022B1 (en) 2006-11-02
PT1325022E (pt) 2006-12-29
CA2419960A1 (en) 2002-03-21
WO2002022646A2 (en) 2002-03-21
IL154776A (en) 2007-07-04
WO2002022646A3 (en) 2002-06-06
JP2004509131A (ja) 2004-03-25
DE60124289T2 (de) 2007-09-06
US20050277769A1 (en) 2005-12-15
US20040092733A1 (en) 2004-05-13
US20090216008A1 (en) 2009-08-27
EP1325022A2 (en) 2003-07-09
IL154776A0 (en) 2003-10-31
US7071328B2 (en) 2006-07-04
WO2002022646A9 (en) 2002-09-19
DE60124289D1 (de) 2006-12-14
US20070249826A1 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
DK1325022T3 (da) Fremgangsmåde til fremstilling af 21-hydroxy-6,19-oxidoprogesteron (21OH-6OP)
DK1255719T3 (da) Integreret fremgangsmåde til fremstilling af en alkenylsubstitueret aromatisk forbindelse
DK1385826T3 (da) Fremgangsmåde til fremstilling af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azapin-5-carboxamid
DK1427286T3 (da) Fremgangsmåde til udtynding af frugt
DK1335995T3 (da) Fremgangsmåde til fremstilling af en fordampningskilde
DK1118268T3 (da) Fremgangsmåde til kryokonservering af zebrafiskesperm
DK1246813T3 (da) Fremgangsmåde til fremstilling af Citalopram
DK1324760T3 (da) Creatin-esterholdige pronæringsstoforbindelser og formuleringer
DK1347984T3 (da) Fremgangsmåde til fremstilling af taxanderivater
ATE283311T1 (de) Vorvernetzungshemmende zusammensetzung
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
DK1339703T3 (da) Fremgangsmåde til fremstilling af paclitaxel
DK1395587T3 (da) Fremgangsmåde til fremstilling af imipenem
DK1401846T3 (da) Fremgangsmåde til udvinding af N-phosphonomethylglycin
DK1358179T3 (da) Syntesefremgangsmåde og mellemprodukter af pyridin-2-yl-methylamin
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
DK1086114T3 (da) Morfin-6-glucuronidsyntese
AR025435A1 (es) Metodo para sintetizar mezclas de oligosacaridos derivados de (fosfato-ribosa-ribitol)n o de (ribosa-ribitol-fosfato)n y disacaridos intermedios de los mismos
DK1385806T3 (da) Ettrinsfremgangsmåde til fremstilling af trimethoxytoluen
DK1315702T3 (da) Fremgangsmåde til fremstilling af halogen-4-phenoxyquinoliner
DK1309583T3 (da) Fremgangsmåde til fremstilling af discodermolid og analoge deraf
DK1064294T3 (da) 5-imino-13-deoxyanthracyclin-derivater, deres vendelse og fremgangsmåde til fremstilling af disse
DK1383737T3 (da) Fremgangsmåde til fremstillingen af alkyl-N-(3-dimethylamino)alkylcabamater